Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

Negative Lymph Node ◽

Node Negative Breast Cancer ◽

Multigene Signatures

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer

PLoS ONE ◽

10.1371/journal.pone.0207155 ◽

2018 ◽

Vol 13 (11) ◽

pp. e0207155 ◽

Cited By ~ 4

Author(s):

Mi Jeong Kwon ◽

Sae Byul Lee ◽

Jinil Han ◽

Jeong Eon Lee ◽

Jong Won Lee ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Node Negative ◽

Asian Patients ◽

Negative Lymph Node ◽

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

SpringerPlus ◽

10.1186/s40064-015-0840-y ◽

2015 ◽

Vol 4 (1) ◽

Cited By ~ 8

Author(s):

Nikhil G Thaker ◽

Karen E Hoffman ◽

Michael C Stauder ◽

Simona F Shaitelman ◽

Eric A Strom ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Node Negative ◽

Clinical significance of 21-gene recurrence score assay for hormone receptor–positive, lymph node-negative breast cancer in early stage

Experimental and Molecular Pathology ◽

10.1016/j.yexmp.2019.04.013 ◽

2019 ◽

Vol 108 ◽

pp. 150-155

Author(s):

Yang Yu-qing ◽

Wang Lei ◽

Huang Mei-ling ◽

Xiao Jing-jing ◽

Wei Mei-chen ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Clinical Significance ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Positive Lymph Node ◽

Node Negative ◽

Evaluation of Prognosis in Hormone Receptor–Positive/HER2-Negative and Lymph Node–Negative Breast Cancer With Low Oncotype DX Recurrence Score

Clinical Breast Cancer ◽

10.1016/j.clbc.2017.12.006 ◽

2018 ◽

Vol 18 (5) ◽

pp. 347-352 ◽

Cited By ~ 2

Author(s):

Jane Meisel ◽

Chao Zhang ◽

Cameron Neely ◽

Pia Mendoza ◽

Shuo You ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Oncotype Dx Recurrence Score

Association of endocrine therapy with overall survival in women with hormone receptor‐positive, HER2‐negative, node‐negative breast cancer of favorable histology

The Breast Journal ◽

10.1111/tbj.13995 ◽

2020 ◽

Vol 26 (10) ◽

pp. 2006-2010

Author(s):

Oluwadamilola T. Oladeru ◽

Anurag K. Singh ◽

Sung Jun Ma

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Node Negative ◽

Favorable Histology ◽

Association of Survival With Chemoendocrine Therapy in Women With Small, Hormone Receptor–Positive, ERBB2-Positive, Node-Negative Breast Cancer

JAMA Network Open ◽

10.1001/jamanetworkopen.2020.2507 ◽

2020 ◽

Vol 3 (4) ◽

pp. e202507

Author(s):

Sung Jun Ma ◽

Oluwadamilola T. Oladeru ◽

Anurag K. Singh

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Positive Node ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Chemoendocrine Therapy

Evaluation of non-genomic, clinical risk and survival results in endocrine-sensitive, HER2-negative, lymph node negative breast cancer

Medicina Clínica (English Edition) ◽

10.1016/j.medcle.2018.10.011 ◽

2018 ◽

Vol 151 (12) ◽

pp. 469-475

Author(s):

José M. Baena Cañada ◽

Salvador Gámez Casado ◽

Lourdes Rodríguez Pérez ◽

Alicia Quílez Cutillas ◽

Cristina Cortés Carmona ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Node Negative ◽

Clinical Risk ◽

Negative Lymph Node ◽

Early economic benefits of gene expression profiling using a 21-gene panel among patients with early stage, lymph node negative, hormone receptor positive, her2-neu oncogene negative breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e18255 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e18255-e18255

Author(s):

Stanley E. Waintraub ◽

Donna M. McNamara ◽

Deena Atieh Graham. ◽

Andrew Pecora ◽

John Min ◽

...

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Lymph Node ◽

Hormone Receptor ◽

Expression Profiling ◽

Early Stage ◽

Economic Benefits ◽

Node Negative ◽

Neu Oncogene

Abstract P3-02-02: Cyclin D1 overexpression increases the risk for breast cancer death 4-fold in hormone receptor positive and node negative breast cancer

10.1158/0008-5472.sabcs13-p3-02-02 ◽

2013 ◽

Author(s):

C Ahlin ◽

M Grönberg ◽

A Valachis ◽

W Zhou ◽

R-M Amini ◽

...

Keyword(s):

Breast Cancer ◽

Cyclin D1 ◽

Hormone Receptor ◽

Cancer Death ◽

Node Negative ◽

Breast Cancer Death ◽

Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05902-0 ◽

2020 ◽

Vol 184 (3) ◽

pp. 915-925

Author(s):

Yunan Han ◽

Zhi-Feng Miao ◽

Min Lian ◽

Lindsay L. Peterson ◽

Graham A. Colditz ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Ethnic Disparities ◽

Positive Node ◽

Racial And Ethnic Disparities ◽

Node Negative ◽